about
Launching invasive, first-in-human trials against Parkinson's disease: ethical considerationsA monoclonal antibody-GDNF fusion protein is not neuroprotective and is associated with proliferative pancreatic lesions in parkinsonian monkeysIntraoperative intracerebral MRI-guided navigation for accurate targeting in nonhuman primatesRisk of surgical delivery to deep nuclei: a meta-analysisNeurobehavioral development of common marmoset monkeys.Development of a novel postnatal neurobehavioral scale for evaluation of common marmoset monkeysNonuniform cardiac denervation observed by 11C-meta-hydroxyephedrine PET in 6-OHDA-treated monkeysMood, memory and movement: an age-related neurodegenerative complex?Cell-based therapies for Parkinson's disease: past, present, and futureTiter and product affect the distribution of gene expression after intraputaminal convection-enhanced delivery.Cardiac sympathetic denervation in 6-OHDA-treated nonhuman primates.Evaluation of hydrodynamic limb vein injections in nonhuman primates.Systemic administration of 6-OHDA to rhesus monkeys upregulates HLA-DR expression in brain microvasculatureExpression of peroxisome proliferator-activated receptor-gamma in the substantia nigra of hemiparkinsonian nonhuman primatesNonhuman primate models of Parkinson's disease.Preclinical assessment of stem cell therapies for neurological diseases.The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys.Strategies for improving animal models for regenerative medicineBlood vessels and parkinsonism.Cell transplantation for Parkinson's disease.Research ethics. Beyond access vs. protection in trials of innovative therapies.Evaluation of animal models of Parkinson's disease for neuroprotective strategies.The Relation between Catheter Occlusion and Backflow during Intraparenchymal Cerebral Infusions.Specification of midbrain dopamine neurons from primate pluripotent stem cells.α-Synuclein and nonhuman primate models of Parkinson's diseaseInduced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brain.Pathways of infusate loss during convection-enhanced delivery into the putamen nucleusIntracerebral transplantation of differentiated human embryonic stem cells to hemiparkinsonian monkeys.Contributions of non-human primates to neuroscience research.Neuroprotective Properties of a Novel Non-Thiazoledinedione Partial PPAR- γ Agonist against MPTP.Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone Effects.SIMULATING CONVECTION-ENHANCED DELIVERY IN THE PUTAMEN USING PROBABILISTIC TRACTOGRAPHY.Can we prevent parkinson's disease?Neurotoxin-Induced Catecholaminergic Loss in the Colonic Myenteric Plexus of Rhesus MonkeysModeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease.Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Adult Common Marmoset Fibroblasts.The role of nonhuman primate models in the development of cell-based therapies for Parkinson's disease.GDNF-secreting human neural progenitor cells increase tyrosine hydroxylase and VMAT2 expression in MPTP-treated cynomolgus monkeys.Real-Time Intraoperative MRI Intracerebral Delivery of Induced Pluripotent Stem Cell-Derived Neurons.Overexpressing Corticotropin-Releasing Factor in the Primate Amygdala Increases Anxious Temperament and Alters Its Neural Circuit
P50
Q24289526-17AB545A-DE94-42BF-91E0-60B4AC8ED828Q28728201-B7C83366-6576-4368-9D4A-9ACF13950932Q28732112-286C0150-D80C-485E-9B45-31D2A5281063Q30371423-2AF7897A-E5F9-4334-B468-13F1BAE269E7Q30375150-257849F4-7E1E-49BA-B150-8BFE6ABE63D5Q30386882-63A116B8-2510-45E4-8B9D-793B6CB48B0EQ31059759-1EBAFCC3-02B2-4B38-8D24-7741A147B12BQ33554878-841350C6-C288-4FCD-9024-63BA52100001Q33818127-A30846D7-ECF2-476A-9591-9F4218776F48Q34024890-74C99BFA-B58B-4B19-B846-9B1CFA35FA8BQ34061568-AE323803-E2D6-44EA-8A81-ED900FC2242DQ34123298-39667505-6FF7-4D86-B942-E589A80A5145Q34237258-652CABD7-E9AC-4E5C-92F4-62B7A79A7683Q34626758-C83265B2-FB76-4DB6-BBB6-92516182C402Q34665820-07659715-5B0A-464B-BAB1-D7F2E5EDB454Q34786764-79435733-74C3-473B-9167-145C110A68BEQ35196195-EB71FABF-4567-4B6A-97AC-44CCFD8CAB62Q35249047-AB53BE42-705F-4C19-BB32-457C93A2779BQ35650801-345DB21F-AC93-423C-83E5-A422F70A5A7EQ35806033-B64A663D-B3CA-4E79-98C3-2D416D865468Q35893072-93225FD2-B48C-4618-A06A-A6609B33065FQ35920006-5EBFD070-8EC9-440E-9F4D-738A1A2AC44BQ35967758-16747006-C7CC-4822-B89D-F5549AF96CC6Q36117009-E9BA7B1A-F851-41EF-BD97-6E936E526F1FQ36157306-A88FA8F3-FB67-4BEC-B0FC-B8A145730FE8Q36787847-AFAD0A01-F10E-4CC4-B288-CE26C4A0D520Q37026271-55F4CA00-C83B-4449-8605-6CCEC961338BQ37057134-8C3B07BD-5570-4CBF-AFCB-233A4171647AQ37122421-231EF86E-33C3-4990-9DA1-F4B000C1E8EDQ37256315-1B0AB455-D0EB-4180-B881-CAF9AD48B316Q37334469-321145F4-08F9-426C-80D4-88880F2B8575Q37370495-6ECAA91B-4494-4E77-B8CC-DA39CBA68096Q37410157-ACE8646A-46C3-498B-A27E-4C637348DF22Q37579221-E019BC66-90ED-4349-9D48-1F3EF6391F12Q37711062-7FC4C58D-6DFC-446F-BD86-CCBD7D4B8305Q38699556-E6B5F1F9-6373-4777-9619-D990A60FEC98Q39192172-278F1F9B-DA6F-42A6-967F-9A82FFD818C6Q39975890-7C5E43D8-DE28-478B-BAF1-076AA8262F13Q40579402-F71625AD-6720-47A4-87E0-95E0DA761E27Q40832553-714A70B1-F07F-4CB6-8672-B5466F7127D8
P50
name
Marina Elena Emborg
@ast
Marina Elena Emborg
@en
Marina Elena Emborg
@es
Marina Elena Emborg
@nl
type
label
Marina Elena Emborg
@ast
Marina Elena Emborg
@en
Marina Elena Emborg
@es
Marina Elena Emborg
@nl
prefLabel
Marina Elena Emborg
@ast
Marina Elena Emborg
@en
Marina Elena Emborg
@es
Marina Elena Emborg
@nl